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BACKGROUND 
 
• Otitis media (OM) accounts 
for the majority of cases of 
childhood hearing loss diagnosed 
by audiologists.  
• Considerable confusion exists 
regarding the distinction between 
otitis media with effusion, also 
known as middle ear effusion or 
“glue ear”, and acute otitis media, 
the quintessential ear infection. 
• Doctors fail to educate their 
patients properly about their 
benefits and risks of treatment 
options. 
• Uncertainty remains among 
physicians regarding the 
comparative benefits and costs of 
the various treatment strategies, 
due to the lack of consensus on 
clinical and long-term functional 
outcomes of otitis media with 
effusion (Berkman et. al, 2013).  
 
PURPOSE 
• To present otitis media with  
effusion versus acute otitis media 
within the framework of their 
anatomy and pathophysiology 
• To address all methods  
currently used to treat otitis media 
with effusion and acute otitis 
media among children through 
age 12 with no pre-existing 
conditions 
• To propose a preferred way of  
treating middle ear effusion. 
 
METHODS:  
• A database search was  
conducted to identify studies on 
the causes, sequelae, and 
epidemiology of otitis media, as 
well as its treatments. 
• Criteria for diagnosis as acute  
otitis media and otitis media with 
effusion were clearly established, 
and the evidence from relevant 






• Acute otitis media (AOM): The rapid onset of signs and symptoms of inflammation in the 
middle ear (Lieberthal et. al, 2013) Hallmark symptoms: fever and otalgia. 
• Recurrent AOM: 3 or more separate AOM episodes in the preceding 6 months or 4 or 
more episodes in the preceding 12 months with at least 1 episode in the past 6 months. 
• Otitis media with effusion (OME): The collection of fluid in the middle ear; the signs and 
symptoms of acute inflammation or infection are absent (Perera et. al, 2013). Does not 
represent an acute infectious process that benefits from antibiotics. 
• Prolonged effusion: Effusion lasting 3 months or more 
• Relationship between AOM and OME: Effusion may become infected secondarily due to 
an ascending infection from Eustachian tube into the middle ear cleft. Conversely, 67% of 
patients develop a middle ear effusion after an episode of AOM (Waseem et. al, 2014). 
 
PREVALENCE 
• AOM: Peak incidence between 6 and 24 months (Waseem et. al, 2014) 
• OME: Typically affects children between 3 and 7 years old (van Zon et. al, 2012). 
• As of 2007, the annual prevalence of otitis media diagnoses in children younger than 18 
was 247 per 1000 children (National Center for Health Statistics, 2011). Highest rates of 
otitis media are represented by children aged 3 and younger (Klein et. al, 2008). 
 
EVIDENCE-BASED TREATMENT 
  Watchful Waiting (WW): Most children improve eventually irrespective of management 
(Rosenfeld & Kay, 2003). American Academy of Pediatrics (Lieberthal et. al, 2013) currently 
supports 48-72 hours of “watchful waiting” in which only pain medications are utilized. After 
this stage, the child is re-evaluated and only then prescribed antibiotics if symptoms appear to 
persist or worsen. 
  Medical and surgical treatment for AOM:  
• Antibiotics (Amoxicillin) 
• Tympanostomy tubes to minimize recurrent AOM 
  Medical and surgical treatment for OME: 
• 3-month period of observation with serial audiometry and assessment of the degree of 
hearing loss and the impact on a child’s development before determining the need for tx. 
• Antibiotics are the only medical tx with measurable benefits. 
• Myringotomy: Incision is made into the tympanic membrane and all fluid is removed using 
suction. 
• Tympanostomy tubes (TT): A ventilation tube is placed at the incision site through the 
eardrum, to keep the middle ear aerated for a prolonged time and to prevent 
reaccumulation of fluid. 
• Adenoidectomy: Surgical removal of the adenoids, for children with recurrent OM 
previously treated with tympanostomy tubes, either alone or combined with tonsillectomy. 
 Alternative treatment options for otitis media: 
• Autoinflation: Technique which opens and forces air through the eustachian tube by raising 
pressure in the nose, thereby equalizing the pressure in the middle ear and allowing better 
drainage of effusion. Beneficial effect on the clinical resolution of middle ear effusion at 
least in the short term (Perera et. al, 2013). Ex: Politzer Method, EarPopper, Otovent 
                           DISCUSSION 
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• 61% of children have spontaneous 
symptomatic relief within 24 hours of 
diagnosis of AOM; 80% by 2-3 days and 
70% at 7-14 days. A relative increase of 30-
50% in spontaneous resolution from OME is 
observed if watchful waiting period is 
extended from 3 to 6 months. 
• Compared to WW, TT is promptly effective 
in reducing effusion and improving hearing 
(Berkman et. al, 2013). The marginal benefit 
with respect to hearing thresholds is 
observed up to 6 months after tube 
placement.  
• Repeated antibiotic use can lead to 
decreased appetite, failure to thrive, and a 
longer term resistance even on a population 
level.  
• Risks of anesthesia can be avoided. 
• The prompt improvement in hearing offered 
by TT may not be absolutely necessary if the 
child is being closely monitored and 
developing well. 
• The evidence regarding developmental delay 
specifically associated with untreated otitis 
media in the short term is highly uncertain 
and leaves room to believe that the long-term 
outcomes are similar regardless of the 
treatment course.  
• In contrast to the traditional methods which 
only treat the symptoms of OME, autoinflation 
techniques target the underlying eustachian 
tube dysfunction in efforts of providing more 
lasting effects. By the adopting these 
practical techniques at home, the 
improvement noticed over the period of 
watchful waiting holds even greater potential. 
 
 
